mutations and complicated kar yotype. It follows a linear evolution within the CLL clone with the recurrent acquisition of CDKN2A Not all patients with CLL involve therapy. Even with all latest advances, the iwCLL however suggests watchful observation for patients with asymptomatic disorder.86 Th